Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis.
Saved in:
| Title: | Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis. |
|---|---|
| Authors: | Kircik LH; Icahn School of Medicine at Mount Sinai, New York, NY, USA. wedoderm@yahoo.com.; Indiana University School of Medicine, Indianapolis, IN, USA. wedoderm@yahoo.com.; Physicians Skin Care, PLLC, 1169 Eastern Pkwy #2310, Louisville, KY, 40217, USA. wedoderm@yahoo.com.; DermResearch, PLLC, Louisville, KY, USA. wedoderm@yahoo.com.; Skin Sciences, PLLC, Louisville, KY, USA. wedoderm@yahoo.com., Stein Gold L; Henry Ford Hospital, Detroit, MI, USA., Gold M; Tennessee Clinical Research Center, Nashville, TN, USA., Weiss JS; Georgia Dermatology Partners, Snellville, GA, USA.; Gwinnett Clinical Research Center, Inc., Snellville, GA, USA., Harper JC; Dermatology & Skin Care Center of Birmingham, Birmingham, AL, USA., Del Rosso JQ; JDR Dermatology Research/Thomas Dermatology, Las Vegas, NV, USA.; Advanced Dermatology and Cosmetic Surgery, Maitland, FL, USA.; Touro University Nevada, Henderson, NV, USA., Bunick CG; Department of Dermatology and Program in Translational Biomedicine, Yale University, New Haven, CT, USA., Bhatia N; Therapeutics Clinical Research, San Diego, CA, USA., Tanghetti EA; Center for Dermatology and Laser Surgery, Sacramento, CA, USA., Eichenfield LF; School of Medicine, University of California, San Diego, CA, USA.; Rady Children's Hospital, San Diego, CA, USA., Baldwin H; The Acne Treatment and Research Center, Brooklyn, NY, USA.; Robert Wood Johnson University Hospital, New Brunswick, NJ, USA., Draelos ZD; Dermatology Consulting Services, PLLC, High Point, NC, USA., Callender VD; Callender Dermatology and Cosmetic Center, Glenn Dale, MD, USA.; Howard University College of Medicine, Washington, DC, USA., Han G; Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York, NY, USA., Gooderham MJ; Queens University, Peterborough, ON, Canada.; SKiN Centre for Dermatology and Probity Medical Research, Peterborough, ON, Canada., Sadick N; Weill Cornell Medical College, New York, NY, USA.; Sadick Dermatology, New York, NY, USA., Lupo MP; Lupo Center for Aesthetic and General Dermatology, New Orleans, LA, USA., Lain ET; Austin Institute for Clinical Research, Austin, TX, USA., Werschler WP; Elson S. Floyd College of Medicine, Washington State University, Spokane, WA, USA. |
| Source: | Dermatology and therapy [Dermatol Ther (Heidelb)] 2024 May; Vol. 14 (5), pp. 1211-1227. Date of Electronic Publication: 2024 May 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Healthcare Communications Country of Publication: Switzerland NLM ID: 101590450 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8210 (Print) NLM ISO Abbreviation: Dermatol Ther (Heidelb) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2193-8210 |
|---|---|
| DOI: | 10.1007/s13555-024-01155-7 |
